|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$970||Benefits minus costs||$9,763|
|Participants||$917||Benefit to cost ratio||$47.61|
|Others||$564||Chance the program will produce|
|Indirect||$7,520||benefits greater than the costs||98 %|
|Net program cost||($209)|
|Benefits minus cost||$9,763|
|Detailed Monetary Benefit Estimates Per Participant|
|Benefits from changes to:1||Benefits to:|
|Health care associated with low birthweight births||$47||$2||$47||$24||$119|
|From secondary participant|
|Health care associated with NICU admissions||$517||$21||$517||$261||$1,316|
|Adjustment for deadweight cost of program||$0||$0||$0||($106)||($106)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$446||2016||Present value of net program costs (in 2016 dollars)||($209)|
|Comparison costs||$237||2016||Cost range (+ or -)||30 %|
|Estimated Cumulative Net Benefits Over Time (Non-Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in non-discounted dollars to simplify the “break-even” point from a budgeting perspective. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment Age||Primary or secondary participant||No. of effect sizes||Treatment N||Adjusted effect sizes (ES) and standard errors (SE) used in the benefit-cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
|Low birthweight births (< 2500g)***||27||Primary||4||151||-0.494||0.217||27||0.000||0.000||28||-0.494||0.023|
|Preterm birth (< 37 weeks)***||27||Primary||5||457||-0.340||0.130||27||0.000||0.000||28||-0.340||0.009|
|Smoking during late pregnancy^||27||Primary||7||516||-0.752||0.110||27||0.000||0.000||28||-0.752||0.001|
|Low birthweight births (< 2500g)***||1||Secondary||4||151||-0.494||0.217||1||0.000||0.000||2||-0.494||0.023|
|Preterm birth (< 37 weeks)***||1||Secondary||5||457||-0.340||0.130||1||0.000||0.000||2||-0.340||0.009|
Heil, S.H., Higgins, S.T., Bernstein, I.M., Solomon, L.J., Rogers, R.E., Thomas, C.S., . . . Lynch, M.E. (2008). Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction 103(6), 1009-18.
Higgins, S.T., Heil, S.H., Solomon, L.J., Bernstein, I.M., Lussier, J.P., Abel, R.L., . . . Badger, G.J. (2004). A pilot study on voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum. Nicotine & Tobacco Research, 6(6), 1015-20.
Higgins, S.T., Washio, Y., Lopez, A.A., Heil, S.H., Solomon, L.J., Lynch, M.E., . . . Bernstein, I.M. (2014). Examining two different schedules of financial incentives for smoking cessation among pregnant women. Preventive Medicine, 68, 51-57.
Ondersma, S.J., Svikis, D.S., Lam, P.K., Connors-Burge, V.S., Ledgerwood, D.M., & Hopper, J.A. (2012). A randomized trial of computer-delivered brief intervention and low-intensity contingency management for smoking during pregnancy. Nicotine & Tobacco Research, 14(3), 351-60.
Tappin, D., Bauld, L., Purves, D., Boyd, K., Sinclair, L., MacAskill, S., . . . Cessation in Pregnancy Incentives Trial Team. (2015). Financial incentives for smoking cessation in pregnancy: randomized controlled trial. BMJ (Clinical Research Ed.), 350, h134.
Tuten, M., Fitzsimons, H., Chisolm, M.S., Nuzzo, P.A., & Jones, H.E. (2012). Contingent incentives reduce cigarette smoking among pregnant, methadone-maintained women: results of an initial feasibility and efficacy randomized clinical trial. Addiction, 107(10), 1868-1877.